Oceanía · Mercados regionales · Stockhead

Recce inks Australia and NZ licensing deal for diabetic foot infections gel

Publicado por Stockhead · Australia hace 1 h

Under the deal, Arrotex will obtain exclusive commercialisation rights for R327G in Australia and New Zealand. ... Read More The post Recce inks Australia and NZ licensing deal…

Leer el artículo completo en Stockhead Inicie sesión para guardar

MarketNews muestra el titular y el resumen publicados por el medio. El artículo completo se lee en el sitio del editor. (stockhead.com.au)

Recce inks Australia and NZ licensing deal for diabetic foot infections gel

También te puede interesar

The West confronts the reality of unconditional tolerance

Gingerah's 1GW data centre, 6.7GW renewables project joins EPBC queue

Pumped hydro project scrapped after developer deems it unviable

Victoria’s government-backed Alice Anderson Fund for women founders scores another $10 million

IFM continues global infra drive with appointment, acquisition

Cuttable raises $20 million to help brands post social media ads at scale

Recce inks Australia and NZ licensing deal for diabetic foot infections gel

Compartir

También te puede interesar

The West confronts the reality of unconditional tolerance

Gingerah's 1GW data centre, 6.7GW renewables project joins EPBC queue

Pumped hydro project scrapped after developer deems it unviable

Victoria’s government-backed Alice Anderson Fund for women founders scores another $10 million

IFM continues global infra drive with appointment, acquisition

Cuttable raises $20 million to help brands post social media ads at scale